RecruitingNot ApplicableNCT03603730
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
Modulation of Gastric Sensitivity and Accommodation by Vagal Nerve Stimulation
Sponsor
Massachusetts General Hospital
Enrollment
65 participants
Start Date
Nov 30, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
Explore the effects of auricular transcutaneous vagal nerve stimulation (taVNS) on brain and stomach outcomes in functional dyspepsia and gastroparesis patients.
Eligibility
Min Age: 18 YearsMax Age: 70 Years
Inclusion Criteria9
- Volunteers, female and male, between 18 and 65 years of age.
- For healthy volunteers, ability to undergo MRI for up to 2 hours.
- For Functional Dyspeptic patients, diagnosis according to the Rome III criteria for both PDS and EPS subtypes.
- For Gastroparesis patients, diagnosis will include the following criteria:
- symptoms of gastroparesis of at least 12 weeks duration (does not have to be continuous) with varying degrees of nausea, vomiting, early satiety, and/or post-prandial fullness
- an idiopathic etiology
- abnormal gastric emptying scintigraphy (GES) results using a 4 hour low fat Egg Beaters® protocol within the last 6 months with either a gastric emptying rate \> 60% retention at 2 hours and/or \>10% retention at 4 hours.
- \) Stable medical treatment for Functional Dyspeptic or Gastroparesis during 1 month before study and during the study period.
- \) Avoidance of alcohol, nicotine, and caffeine for 24 hours prior to study session.
Exclusion Criteria31
- History gastric/esophageal surgery
- Any alternative treatment (e.g. acupuncture, hypnosis etc.) two weeks prior to the study or during the study period.
- Illicit drugs or opioid use.
- History of arrhythmias.
- Implanted pacemaker.
- Epilepsy or a prior history of seizures.
- For Gastroparesis patients, inability to comply with or complete GES test (including allergy to eggs).
- Pregnancy or nursing or plans to become pregnant.
- Inability to provide informed consent.
- BMI more than 32 and/or weight \> 235 lbs. (limits of the MRI table).
- Contraindications for MRI: High magnetic fields may pose a serious health hazard to subjects with implanted ferromagnetic objects. Every subject in this study will be carefully screened before entering the high magnetic field shielded room to collect a precise outline of the subject's medical history. Subjects with the following characteristics/disease may not be eligible to participate in the study and will require additional screening:
- History of Head Trauma
- Any metallic implants (e.g. braces or permanent retainers)
- Tattoos with metallic ink above the nipple line
- Surgical Aneurysm Clips
- Cardiac Pacemaker
- Prosthetic Heart Valve
- Neurostimulator
- Implanted pumps
- Cochlear Implants
- Metal rods, Plates, Screws
- Recent Previous Surgery
- IUD
- Hearing Aid
- Dentures (which might create NMR artifacts)
- Metal Injury to eyes
- Pregnancy or plans to become pregnant
- Breast Feeding
- Meniere's Disease
- Transdermal (skin) patches such as NicoDerm (nicotine for tobacco dependence), Transderm Scop, or Ortho Evra (birth control)
- Claustrophobia
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEtaVNS
Active or inactive taVNS delivered to the external ear at a moderate, non-painful level.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03603730
Related Trials
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
NCT046612155 locations
GpCRC Pediatric Gastroparesis Registry 2
NCT059813006 locations
Gastroparesis Registry 4
NCT058468026 locations
Study of Gastric Motility in Eosinophilic Gastritis
NCT052294323 locations
Compassionate Use of Domperidone for Refractory Gastroparesis
NCT046995911 location